アルツハイマー病診断検査:医療機器パイプライン分析2017

◆英語タイトル:Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017
◆商品コード:GDME0447EPD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年9月12日
◆ページ数:378
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥896,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,344,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Alzheimer Diagnostic Tests – Medical Devices Pipeline Assessment, 2017
Summary

GlobalData’s Medical Devices sector report, “Alzheimer Diagnostic Tests – Medical Devices Pipeline Assessment, 2017″ provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Alzheimer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Alzheimer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Alzheimer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 17
2 Introduction 18
2.1 Alzheimer Diagnostic Tests Overview 18
3 Products under Development 19
3.1 Alzheimer Diagnostic Tests – Pipeline Products by Stage of Development 19
3.2 Alzheimer Diagnostic Tests – Pipeline Products by Territory 20
3.3 Alzheimer Diagnostic Tests – Pipeline Products by Regulatory Path 21
3.4 Alzheimer Diagnostic Tests – Pipeline Products by Estimated Approval Date 22
3.5 Alzheimer Diagnostic Tests – Ongoing Clinical Trials 23
4 Alzheimer Diagnostic Tests – Pipeline Products under Development by Companies 24
4.1 Alzheimer Diagnostic Tests Companies – Pipeline Products by Stage of Development 24
4.2 Alzheimer Diagnostic Tests – Pipeline Products by Stage of Development 29
5 Alzheimer Diagnostic Tests Companies and Product Overview 34
5.1 AC Immune SA Company Overview 34
5.2 Acobiom Company Overview 36
5.3 Acumen Pharmaceuticals Inc Company Overview 38
5.4 Adlyfe Inc Company Overview 39
5.5 Advanced Genomic Technology, LLC Company Overview 40
5.6 ADx NeuroSciences NV Company Overview 41
5.7 Aelan Cell Technologies Company Overview 50
5.8 Akrivis Technologies LLC Company Overview 51
5.9 Albert Ludwigs University of Freiburg Company Overview 52
5.10 Alere Inc Company Overview 53
5.11 Alzhyme Pty Ltd Company Overview 54
5.12 Amarantus Bioscience Holdings Inc Company Overview 55
5.13 Amoneta Diagnostics SAS Company Overview 58
5.14 Amprion Inc Company Overview 59
5.15 Applied NeuroSolutions, Inc. (Inactive) Company Overview 60
5.16 Applied Proteomics Inc Company Overview 61
5.17 Arkley Biotek LLC Company Overview 62
5.18 Avant Diagnostics, Inc. Company Overview 63
5.19 Banyan Biomarkers Inc Company Overview 64
5.20 BioArctic AB Company Overview 65
5.21 Bioasis Technologies Inc Company Overview 66
5.22 Biocross SL Company Overview 67
5.23 Biomedical Development Corp Company Overview 71
5.24 BioSystems International Company Overview 72
5.25 C2N Diagnostics LLC Company Overview 73
5.26 Chronix Biomedical Inc Company Overview 74
5.27 Cleveland Diagnostics Inc. Company Overview 75
5.28 Cofactor Genomics Inc Company Overview 76
5.29 Cognoptix Inc Company Overview 77
5.30 Columbia University Company Overview 80
5.31 CompanDX Ltd. Company Overview 82
5.32 Consejo Superior de Investigaciones Cientificas Company Overview 83
5.33 Cymedx Company Overview 84
5.34 Cytox Ltd Company Overview 85
5.35 DiaGenic ASA Company Overview 88
5.36 DiaPat GmbH Company Overview 90
5.37 Diaxonhit SA Company Overview 91
5.38 Dr. Grossegger & Drbal GmbH Company Overview 92
5.39 Durin Technologies, Inc. Company Overview 93
5.40 EMD Millipore Corp Company Overview 94
5.41 Emory University Company Overview 95
5.42 Fianostics GmbH Company Overview 96
5.43 Forschungszentrum Julich GmbH Company Overview 97
5.44 French National Institute of Health and Medical Research Company Overview 98
5.45 Fujirebio Diagnostics Inc Company Overview 99
5.46 Gene Solutions LLC Company Overview 100
5.47 GeneNews Ltd Company Overview 101
5.48 Ghent University Company Overview 102
5.49 Grifols SA Company Overview 103
5.50 HealthTell Inc Company Overview 104
5.51 Hummingbird Diagnostics GmbH Company Overview 105
5.52 IASO BioMed Inc Company Overview 106
5.53 ICDD-sas Company Overview 107
5.54 Innovative Health Diagnostics Company Overview 109
5.55 Instituto de Estructura de la Materia Company Overview 110
5.56 Integrated Diagnostics Inc Company Overview 111
5.57 Janssen Pharmaceutica NV Company Overview 112
5.58 John Hopkins University Company Overview 113
5.59 KineMed Inc Company Overview 114
5.60 Laboratory Corp of America Holdings Company Overview 115
5.61 Leibniz Institute for Age Research – Fritz Lipmann Institute Company Overview 116
5.62 Luminex Corp Company Overview 117
5.63 McGill University Health Center Company Overview 118
5.64 Memory Dx LLC Company Overview 119
5.65 Meso Scale Diagnostics LLC Company Overview 120
5.66 Michigan State University Company Overview 121
5.67 Myriad RBM Inc Company Overview 122
5.68 NanoSomiX, Inc. Company Overview 123
5.69 Nanosphere Inc Company Overview 125
5.70 Neuron Biopharma SA Company Overview 126
5.71 NeuroQuest Ltd Company Overview 127
5.72 Neurotrope Bioscience Inc Company Overview 128
5.73 Newcastle University Company Overview 129
5.74 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview 130
5.75 Oasis Diagnostics Corp Company Overview 131
5.76 Oligomerix inc Company Overview 132
5.77 OPKO Health Inc Company Overview 133
5.78 Orasi Medical, Inc. (Inactive) Company Overview 136
5.79 Oregon Health & Science University Company Overview 137
5.80 Oryzon Genomics SA Company Overview 139
5.81 PeriRx LLC Company Overview 140
5.82 Pre Diagnostics AS Company Overview 141
5.83 Predemtec GmbH Company Overview 142
5.84 ProMIS Neurosciences Inc Company Overview 143
5.85 Proplex Technologies Llc Company Overview 144
5.86 Protagen AG Company Overview 145
5.87 Proteome Sciences Plc Company Overview 146
5.88 Proteomics International Laboratories Ltd Company Overview 149
5.89 Quanterix Corp Company Overview 150
5.90 Redox Diagnostics LLC Company Overview 151
5.91 Roche Diagnostics International Ltd Company Overview 152
5.92 Rockefeller University Company Overview 153
5.93 Rosetta Genomics Ltd Company Overview 154
5.94 Satoris, Inc. Company Overview 155
5.95 Scout Diagnostics, LLC Company Overview 156
5.96 SeNostic GmbH Company Overview 157
5.97 Siemens Healthcare GmbH Company Overview 158
5.98 SomaLogic Inc Company Overview 160
5.99 Synthetic Biologics Inc Company Overview 161
5.100 Takeda Pharmaceuticals International AG Company Overview 162
5.101 TauRx Pharmaceuticals Ltd Company Overview 163
5.102 Trinity College Dublin Company Overview 164
5.103 True Diagnostics Inc Company Overview 165
5.104 University of California Irvine Company Overview 166
5.105 University of Chicago Company Overview 167
5.106 University of Georgia Company Overview 168
5.107 University of Gottingen Company Overview 169
5.108 University of Illinois at Chicago Company Overview 171
5.109 University of Luxembourg Company Overview 173
5.110 University of Maryland Baltimore Company Overview 174
5.111 University of Melbourne Company Overview 175
5.112 University of Nottingham Company Overview 176
5.113 University of Oxford Company Overview 177
5.114 University of South Florida Company Overview 178
5.115 University of Texas Health Science Center at Houston Company Overview 179
5.116 University of Texas Southwestern Medical Center Company Overview 180
5.117 US Biomarkers Inc Company Overview 181
5.118 vall d hebron institut de Recerca Company Overview 182
5.119 Vermillion Inc Company Overview 183
5.120 Vitruvian Biomedical Inc Company Overview 184
5.121 Washington University in St Louis Company Overview 185
5.122 Zoiray Technologies Inc. Company Overview 187
6 Alzheimer Diagnostic Tests – Recent Developments 188
6.1 Aug 28, 2017: biOasis Announces Nominees to the Board of Directors, Chairman Transition and Details of its Annual General Meeting of Shareholders 188
6.2 Aug 24, 2017: LabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer 190
6.3 Aug 22, 2017: Clinical Study Shows that Retinal Imaging may Detect Signs of Alzheimer’s Disease 191
6.4 Aug 21, 2017: biOasis Appoints Doug Williams, MBA, Executive Vice President, Chief Business Officer 192
6.5 Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO’s BioReference Laboratories 193
6.6 Aug 15, 2017: Agilent Technologies Reports Third-Quarter Fiscal Year 2017 Financial Results 194
6.7 Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update 194
6.8 Aug 11, 2017: ProMIS Neurosciences Announces Second Quarter 2017 Results 195
6.9 Aug 09, 2017: AC Immune Reports Second Quarter 2017 Financial Results 197
6.10 Aug 07, 2017: Luminex Reports Second Quarter 2017 Financial Results 198
6.11 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results 199
6.12 Aug 01, 2017: Pfizer Reports Second-Quarter 2017 Results 200
6.13 Aug 01, 2017: Proteome Sciences: Directorate changes 204
6.14 Jul 28, 2017: Merck Announces Second-Quarter 2017 Financial Results 204
6.15 Jul 28, 2017: ORYZON Reports Financial Results and Corporate Update for the 1st Half Ended June 30, 2017 207
6.16 Jul 27, 2017: Bristol-Myers Squibb Reports Second Quarter Financial Results 208
6.17 Jul 26, 2017: LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance 212
6.18 Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017 214
6.19 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 215
6.20 Jul 18, 2017: LabCorp’s William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center 216
6.21 Jul 18, 2017: Hans E. Bishop to Join Agilent’s Board of Directors 216
6.22 Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology 217
6.23 Jul 17, 2017: Governor Abbott Announces Merck IT Hub In Austin 218
6.24 Jul 10, 2017: ProMIS Neurosciences Provides Second Quarter Update for 2017 219
6.25 Jul 06, 2017: Rosetta Genomics Expands Patent Portfolio in Canada, United States, and China 219
7 Appendix 373
7.1 Methodology 373
7.2 About GlobalData 376
7.3 Contact Us 376
7.4 Disclaimer 376

1.1 List of Tables
Table 1: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 21
Table 2: Alzheimer Diagnostic Tests - Pipeline Products by Territory 22
Table 3: Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path 23
Table 4: Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date 24
Table 5: Alzheimer Diagnostic Tests - Ongoing Clinical Trials 25
Table 6: Alzheimer Diagnostic Tests Companies - Pipeline Products by Stage of Development 26
Table 7: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 31
Table 8: AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview 36
Table 9: Abeta-Based Diagnostic Test - Alzheimer´s Disease - Product Status 36
Table 10: Abeta-Based Diagnostic Test - Alzheimer´s Disease - Product Description 36
Table 11: pTau-Based Diagnostic Test - Alzheimer´s Disease - Product Status 37
Table 12: pTau-Based Diagnostic Test - Alzheimer´s Disease - Product Description 37
Table 13: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 38
Table 14: Companion Diagnostic Test - Alzheimer's Disease - Product Status 38
Table 15: Companion Diagnostic Test - Alzheimer's Disease - Product Description 38
Table 16: Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Status 39
Table 17: Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Description 39
Table 18: Acumen Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 19: Ultra-high Sensitivity Companion Diagnostic Assay - Product Status 40
Table 20: Ultra-high Sensitivity Companion Diagnostic Assay - Product Description 40
Table 21: Adlyfe Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 22: Diagnostic Assay - Alzheimer’s Disease - Product Status 41
Table 23: Diagnostic Assay - Alzheimer’s Disease - Product Description 41
Table 24: Advanced Genomic Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview 42
Table 25: Blood MicroRNA-Based AD Diagnostic And Prognostic Kit - Product Status 42
Table 26: Blood MicroRNA-Based AD Diagnostic And Prognostic Kit - Product Description 42
Table 27: ADx NeuroSciences NV Pipeline Products & Ongoing Clinical Trials Overview 43
Table 28: ADDL'S Biomarker Test - Product Status 43
Table 29: ADDL'S Biomarker Test - Product Description 43
Table 30: APO E4 Biomarker Test - Product Status 44
Table 31: APO E4 Biomarker Test - Product Description 44
Table 32: BACE 1 Biomarker Test - Product Status 44
Table 33: BACE 1 Biomarker Test - Product Description 45
Table 34: Blood Based Amyloid Beta Biomarker Test - Product Status 45
Table 35: Blood Based Amyloid Beta Biomarker Test - Product Description 45
Table 36: Cerebrospinal Fluid Based Amyloid Beta Biomarker Test - Product Status 46
Table 37: Cerebrospinal Fluid Based Amyloid Beta Biomarker Test - Product Description 46
Table 38: GLOB. P3N Aß Biomarker Test - Product Status 46
Table 39: GLOB. P3N Aß Biomarker Test - Product Description 47
Table 40: Neurogranin Biomarker Test - Product Status 47
Table 41: Neurogranin Biomarker Test - Product Description 47
Table 42: O-TAU Biomarker Test - Product Status 48
Table 43: O-TAU Biomarker Test - Product Description 48
Table 44: P-tau Biomarker Test - Product Status 48
Table 45: P-tau Biomarker Test - Product Description 49
Table 46: SNAP 25 Biomarker Test - Product Status 49
Table 47: SNAP 25 Biomarker Test - Product Description 49
Table 48: Synuclein Oligo Biomarker Test - Product Status 50
Table 49: Synuclein Oligo Biomarker Test - Product Description 50
Table 50: Total tau Biomarker Test - Alzheimer's Test - Product Status 50
Table 51: Total tau Biomarker Test - Alzheimer's Test - Product Description 51
Table 52: Aelan Cell Technologies Pipeline Products & Ongoing Clinical Trials Overview 52
Table 53: Diagnostic Blood Test - Alzheimer's Disease - Product Status 52
Table 54: Diagnostic Blood Test - Alzheimer's Disease - Product Description 52
Table 55: Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 53
Table 56: Amyloid-ß Biomarker Test - Alzheimer’s Disease - Product Status 53
Table 57: Amyloid-ß Biomarker Test - Alzheimer’s Disease - Product Description 53
Table 58: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 54
Table 59: Mitochondrial Preprotein Based Test - Alzheimer’s Disease - Product Status 54
Table 60: Mitochondrial Preprotein Based Test - Alzheimer’s Disease - Product Description 54
Table 61: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 55
Table 62: Diagnostic Assay - Alzheimer’s Disease - Product Status 55
Table 63: Diagnostic Assay - Alzheimer’s Disease - Product Description 55
Table 64: Alzhyme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
Table 65: Diagnostic Test - Alzheimer’s Disease - Product Status 56
Table 66: Diagnostic Test - Alzheimer’s Disease - Product Description 56
Table 67: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 57
Table 68: Georgetown Assay - Alzheimer's Disease-Exosomes - Product Status 57
Table 69: Georgetown Assay - Alzheimer's Disease-Exosomes - Product Description 57
Table 70: Georgetown Assay - Alzheimer's Disease-Lipids - Product Status 58
Table 71: Georgetown Assay - Alzheimer's Disease-Lipids - Product Description 58
Table 72: NuroPro - Alzheimer’s Disease - Product Status 58
Table 73: NuroPro - Alzheimer’s Disease - Product Description 59
Table 74: Amoneta Diagnostics SAS Pipeline Products & Ongoing Clinical Trials Overview 60
Table 75: Diagnostic Kit - Alzheimer’s Disease - Product Status 60
Table 76: Diagnostic Kit - Alzheimer’s Disease - Product Description 60
Table 77: Amprion Inc Pipeline Products & Ongoing Clinical Trials Overview 61
Table 78: Diagnostic Assay - Alzheimer’s Disease - Product Status 61
Table 79: Diagnostic Assay - Alzheimer’s Disease - Product Description 61
Table 80: Applied NeuroSolutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62
Table 81: P-Tau 231 Test - Product Status 62
Table 82: P-Tau 231 Test - Product Description 62
Table 83: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Table 84: API Diagnostic Test - Alzheimer’s Disease - Product Status 63
Table 85: API Diagnostic Test - Alzheimer’s Disease - Product Description 63
Table 86: Arkley Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 64
Table 87: Blood Test - Alzheimer's Disease - Product Status 64
Table 88: Blood Test - Alzheimer's Disease - Product Description 64
Table 89: Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
Table 90: LymPro CLIA Test - Product Status 65
Table 91: LymPro CLIA Test - Product Description 65
Table 92: Banyan Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 66
Table 93: Diagnostic Assay - Alzheimer's Disease - Product Status 66
Table 94: Diagnostic Assay - Alzheimer's Disease - Product Description 66
Table 95: BioArctic AB Pipeline Products & Ongoing Clinical Trials Overview 67
Table 96: Diagnostic Test - Alzheimer's Disease - Product Status 67
Table 97: Diagnostic Test - Alzheimer's Disease - Product Description 67
Table 98: Bioasis Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 68
Table 99: Cognitest - Product Status 68
Table 100: Cognitest - Product Description 68
Table 101: Biocross SL Pipeline Products & Ongoing Clinical Trials Overview 69
Table 102: ApoE4 Blood Marker Assay - Product Status 69
Table 103: ApoE4 Blood Marker Assay - Product Description 69
Table 104: Diagnostic Assay - Alzheimer's Disease - Product Status 70
Table 105: Diagnostic Assay - Alzheimer's Disease - Product Description 70
Table 106: Biocross SL - Ongoing Clinical Trials Overview 71
Table 107: ApoE4 Blood Marker Assay - Study of the Predictive Markers and the Pathophysiological Mechanisms of Alzheimer's Disease: Transverse and Longitudinal Approach in Anatomical and Functional Multimodal Imaging 72
Table 108: Biomedical Development Corp Pipeline Products & Ongoing Clinical Trials Overview 73
Table 109: Vestibular - Topographical Memory Diagnostic Test - Product Status 73
Table 110: Vestibular - Topographical Memory Diagnostic Test - Product Description 73
Table 111: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 74
Table 112: Diagnostic Test - Alzheimer's Disease - Product Status 74
Table 113: Diagnostic Test - Alzheimer's Disease - Product Description 74
Table 114: C2N Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 75
Table 115: SILK-Aß Assay - Product Status 75
Table 116: SILK-Aß Assay - Product Description 75
Table 117: Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 76
Table 118: Companion Diagnostic Test - Alzheimer’s Disease - Product Status 76
Table 119: Companion Diagnostic Test - Alzheimer’s Disease - Product Description 76
Table 120: Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
Table 121: Blood-Based Diagnostic Test - Alzheimer’s Disease - Product Status 77
Table 122: Blood-Based Diagnostic Test - Alzheimer’s Disease - Product Description 77
Table 123: Cofactor Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview 78
Table 124: RNA Based Diagnostic Test - Alzheimer’s Disease - Product Status 78
Table 125: RNA Based Diagnostic Test - Alzheimer’s Disease - Product Description 78
Table 126: Cognoptix Inc Pipeline Products & Ongoing Clinical Trials Overview 79
Table 127: SAPPHIRE II Eye Test - Product Status 79
Table 128: SAPPHIRE II Eye Test - Product Description 79
Table 129: Cognoptix Inc - Ongoing Clinical Trials Overview 80
Table 130: SAPPHIRE II Eye Test - An Evaluation of Aftobetin-HCl and Fluorescence Detection as Measured by Sapphire II to Determine the Number and Timing of Administrations in Subjects with Normal Cognition, Mild Cognitive Impairment, and Mild Alzheimer's Disease 81
Table 131: SAPPHIRE II Eye Test - Diagnosis of Alzheimer’s Disease via Beta Amyloid Signature in the Eyes Using SAPPHIRE II : A Proof Of Concept Study 81
Table 132: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 82
Table 133: bAPP Diagnostic Test - Alzheimer’s Disease - Product Status 82
Table 134: bAPP Diagnostic Test - Alzheimer’s Disease - Product Description 82
Table 135: Diagnostic Test - Alzheimer’s Disease - Product Status 83
Table 136: Diagnostic Test - Alzheimer’s Disease - Product Description 83
Table 137: CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview 84
Table 138: Biomarker Assay - Alzheimer's Disease - Product Status 84
Table 139: Biomarker Assay - Alzheimer's Disease - Product Description 84
Table 140: Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 85
Table 141: Diagnostic Assay - Alzheimer's Disease - Product Status 85
Table 142: Diagnostic Assay - Alzheimer's Disease - Product Description 85
Table 143: Cymedx Pipeline Products & Ongoing Clinical Trials Overview 86
Table 144: CYMEDX Diagnostic Assay - Alzheimer's Disease - Product Status 86
Table 145: CYMEDX Diagnostic Assay - Alzheimer's Disease - Product Description 86
Table 146: Cytox Ltd Pipeline Products & Ongoing Clinical Trials Overview 87
Table 147: ADpredict Screening Test - Product Status 87
Table 148: ADpredict Screening Test - Product Description 87
Table 149: Cytox Ltd - Ongoing Clinical Trials Overview 88
Table 150: ADpredict Screening Test - Cytox Starts Clinical Evaluation Of Novel Mtor Blood Tests For Dementia 89
Table 151: ADpredict Screening Test - Cytox starts clinical evaluation of novel mTOR blood tests for Mild Cognitive Impairment 89
Table 152: DiaGenic ASA Pipeline Products & Ongoing Clinical Trials Overview 90
Table 153: ADtect PLUS - Product Status 90
Table 154: ADtect PLUS - Product Description 90
Table 155: MCItect ULTRA - Product Status 91
Table 156: MCItect ULTRA - Product Description 91
Table 157: DiaPat GmbH Pipeline Products & Ongoing Clinical Trials Overview 92
Table 158: DiaPat - Alzheimer's Disease Test - Product Status 92
Table 159: DiaPat - Alzheimer's Disease Test - Product Description 92
Table 160: Diaxonhit SA Pipeline Products & Ongoing Clinical Trials Overview 93

1.2 List of Figures
Figure 1: Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development 21
Figure 2: Alzheimer Diagnostic Tests - Pipeline Products by Territory 22
Figure 3: Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path 23
Figure 4: Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date 24
Figure 5: Alzheimer Diagnostic Tests - Ongoing Clinical Trials 25

【掲載企業】

AC Immune SA
Acobiom
Acumen Pharmaceuticals Inc
Adlyfe Inc
Advanced Genomic Technology, LLC
ADx NeuroSciences NV
Aelan Cell Technologies
Akrivis Technologies LLC
Albert Ludwigs University of Freiburg
Alere Inc
Alzhyme Pty Ltd
Amarantus Bioscience Holdings Inc
Amoneta Diagnostics SAS
Amprion Inc
Applied NeuroSolutions, Inc.
Applied Proteomics Inc
Arkley Biotek LLC
Avant Diagnostics, Inc.
Banyan Biomarkers Inc
BioArctic AB
Bioasis Technologies Inc
Biocross SL
Biomedical Development Corp
BioSystems International
C2N Diagnostics LLC
Chronix Biomedical Inc
Cleveland Diagnostics Inc.
Cofactor Genomics Inc
Cognoptix Inc
Columbia University
CompanDX Ltd.
Consejo Superior de Investigaciones Cientificas
Cymedx
Cytox Ltd
DiaGenic ASA
DiaPat GmbH
Diaxonhit SA
Dr. Grossegger & Drbal GmbH
Durin Technologies, Inc.
EMD Millipore Corp
Emory University
Fianostics GmbH
Forschungszentrum Julich GmbH
French National Institute of Health and Medical Research
Fujirebio Diagnostics Inc
Gene Solutions LLC
GeneNews Ltd
Ghent University
Grifols SA
HealthTell Inc
Hummingbird Diagnostics GmbH
IASO BioMed Inc
ICDD-sas
Innovative Health Diagnostics
Instituto de Estructura de la Materia
Integrated Diagnostics Inc
Janssen Pharmaceutica NV
John Hopkins University
KineMed Inc
Laboratory Corp of America Holdings
Leibniz Institute for Age Research - Fritz Lipmann Institute
Luminex Corp
McGill University Health Center
Memory Dx LLC
Meso Scale Diagnostics LLC
Michigan State University
Myriad RBM Inc
NanoSomiX, Inc.
Nanosphere Inc
Neuron Biopharma SA
NeuroQuest Ltd
Neurotrope Bioscience Inc
Newcastle University
Novel Bio-spectrum Technologies Inc
Oasis Diagnostics Corp
Oligomerix inc
OPKO Health Inc
Orasi Medical, Inc.
Oregon Health & Science University
Oryzon Genomics SA
PeriRx LLC
Pre Diagnostics AS
Predemtec GmbH
ProMIS Neurosciences Inc
Proplex Technologies Llc
Protagen AG
Proteome Sciences Plc
Proteomics International Laboratories Ltd
Quanterix Corp
Redox Diagnostics LLC
Roche Diagnostics International Ltd
Rockefeller University
Rosetta Genomics Ltd
Satoris, Inc.
Scout Diagnostics, LLC
SeNostic GmbH
Siemens Healthcare GmbH
SomaLogic Inc
Synthetic Biologics Inc
Takeda Pharmaceuticals International AG
TauRx Pharmaceuticals Ltd
Trinity College Dublin
True Diagnostics Inc
University of California Irvine
University of Chicago
University of Georgia
University of Gottingen
University of Illinois at Chicago
University of Luxembourg
University of Maryland Baltimore
University of Melbourne
University of Nottingham
University of Oxford
University of South Florida
University of Texas Health Science Center at Houston
University of Texas Southwestern Medical Center
US Biomarkers Inc
vall d hebron institut de Recerca
Vermillion Inc
Vitruvian Biomedical Inc
Washington University in St Louis
Zoiray Technologies Inc.

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ アルツハイマー病診断検査:医療機器パイプライン分析2017(Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆